Longevity & Aging
IDO1 inhibition (blocking tryptophan->kynurenine) improves memory
In plain terms: Can blocking an enzyme (IDO1) that both amyloid and tau switch on rescue memory in Alzheimer's models?
Part of: • Aging
One strong mouse/cell study (Science 2024) shows amyloid and tau activate astrocytic IDO1->kynurenine, choking brain glucose use, and that blocking IDO1 restores memory; independent data confirm kynurenine pathway disturbance in human AD but the memory-rescue causal claim rests on this single lab.
📅 Last reviewed: 2026-07-14 ⓘ
Evidence ladder
How far up the ladder this claim has climbed. A high consensus on a low rung means "consistent so far," not "proven in people."
Top evidence so far: Animal studies (Animal)
How the studies fall
What the evidence shows
Audit note (2026-07-14 deep audit, re-graded strong-support→leans-support): Same scope-conflation as lmhr-ldl-causes-plaque. This is an INTERVENTION claim (does inhibiting IDO1 restore memory?).
The evidence (12)
| Source | Grade | Stance | Quality | Finding |
|---|---|---|---|---|
| Minhas PS, Jones JR, Latif-Hernandez A, Sugiura Y, Durairaj AS, Wang Q, Mhatre SD, Uenaka T, Crapser J, Conley T, Ennerfelt H, Jung YJ, Liu L, Prasad P, Jenkins BC, Ay YA, Matrongolo M, Goodman R, Newmeyer T, Heard K, Kang A, Wilson EN, Yang T, Ullian EM, Serrano GE, Beach TG, Wernig M, Rabinowitz JD, Suematsu M, Longo FM, McReynolds MR, Gage FH, Andreasson KI 2024 · Science | animal | supports | high | Cited paper: Abeta & tau activate astrocytic IDO1->KYN, suppressing glycolysis (AhR-dependent); IDO1 inhibition restores hippocampal LTP & memory across AD mouse models + AD-patient cocultures. |
| Johnson LA, Macauley SL 2024 · Science | mechanism | supports | moderate | Science Perspective (Johnson & Macauley) on Minhas et al.: 'Minhas et al. (5) demonstrate that inhibition of the kynurenine (KYN) pathway rescues astrocyte metabolism to restore synaptic activity and spatial memory in preclinical mouse models'. Commentary, no own data; re-describes the Minhas primary (vault s39172838) — review, zero weight. |
| Bakker L, Köhler S, Eussen SJPM, Choe K, van den Hove DLA, Kenis G, Rutten BPF, Ulvik A, Ueland PM, Verhey FRJ, Ramakers IHGB 2023 · Brain Behav Immun | observational | mixed | moderate | Plasma/CSF kynurenines relate variably to AD pathology markers; pathway altered but associations modest/inconsistent. |
| Cespedes M, Jacobs KR, Maruff P, Rembach A, Fowler CJ, Trounson B, Pertile KK, Rumble RL, Rainey-Smith SR, Rowe CC, Villemagne VL, Bourgeat P, Lim CK, Chatterjee P, Martins RN, Ittner A, Masters CL, Doecke JD, Guillemin GJ, Lovejoy DB 2022 · Neurobiol Dis | observational | mixed | moderate | [ASSOCIATION not INTERVENTION - establishes kynurenine-pathway involvement in AD, but does NOT test whether INHIBITING IDO1 restores memory; scope-mismatched to this intervention claim] Systemic kynurenine-pathway perturbations precede progression to dementia independently of amyloid; human cohort, corroborates pathway relevance. |
| Dos Reis RG, Singulani MP, Forlenza OV, Gattaz WF, Talib LL 2025 · Alzheimers Dement | observational | mixed | moderate | [ASSOCIATION not INTERVENTION - establishes kynurenine-pathway involvement in AD, but does NOT test whether INHIBITING IDO1 restores memory; scope-mismatched to this intervention claim] Independent human data: kynurenine-pathway metabolite alterations in AD and Down-syndrome AD; corroborates pathway, not the intervention. |
| Souza LC, Jesse CR, Antunes MS, Ruff JR, de Oliveira Espinosa D, Gomes NS, Donato F, Giacomeli R, Boeira SP 2016 · Brain Behav Immun | animal | supports | moderate | IDO inhibitor 1-MT prevented memory and emotional deficits after intracerebroventricular amyloid-beta in mice. |
| Świątek G 2025 · Int J Mol Sci | animal | supports | low | [preclinical - no human IDO1-inhibitor AD trials exist] Rat study (STZ-induced sporadic AD model, n per group not stated in abstract): minocycline treatment (7 days, 35 mg/kg) improved reference memory (Morris water maze) and reduced anxiet |
| Zhang L, Hu S, Zhu J, Jiang G 2026 · Horm Behav | animal | supports | moderate | In APP/PS1 female mice, IDO1 inhibitor 1-MT reversed cognitive impairment and normalized Trp/Kyn metabolism. |
| Qian C, Yang C, Lu M, Bao J, Shen H, Deng B, Li S, Li W, Zhang M, Cao C 2021 · Theranostics | animal | contradicts | moderate | Directional wrinkle: AhR ACTIVATION (not inhibition) rescues AD-mouse cognition via neprilysin; complicates the IDO1->KYN->AhR-as-harmful framing. |
| Almulla AF, Supasitthumrong T, Amrapala A, Tunvirachaisakul C, Jaleel AKA, Oxenkrug G, Al-Hakeim HK, Maes M 2022 · J Alzheimers Dis | meta-analysis | mixed | moderate | [ASSOCIATION not INTERVENTION - establishes kynurenine-pathway involvement in AD, but does NOT test whether INHIBITING IDO1 restores memory; scope-mismatched to this intervention claim] Meta-analysis: kynurenine/TRYCAT pathway is dysregulated in AD; supports the upstream premise (KYN disturbance) but not the IDO1-inhibition memory rescue. |
| Souza LC, Jesse CR, Del Fabbro L, de Gomes MG, Goes ATR, Filho CB, Luchese C, Pereira AAM, Boeira SP 2017 · Behav Brain Res | animal | supports | low | Swimming exercise reduced IDO/kynurenine activation and improved amyloid-beta-induced behavioral disturbances in mice, implicating IDO1 in cognitive impairment. |
| Minhas PS, Jones JR, Latif-Hernandez A, Sugiura Y, Durairaj AS, Uenaka T, Wang Q, Mhatre SD, Liu L, Conley T, Ennerfelt H, Jung YJ, Prasad P, Jenkins BC, Goodman R, Newmeyer T, Heard K, Kang A, Wilson EN, Ullian EM, Serrano GE, Beach TG, Rabinowitz JD, Wernig M, Suematsu M, Longo FM, McReynolds MR, Gage FH, Andreasson KI 2024 · bioRxiv | animal | supports | moderate | Preprint of the Science study showing IDO1 inhibition restores hippocampal glucose metabolism and rescues memory across amyloid and tau models. |
Disagree, or know a study we missed?
We grade by evidence, not opinions. The way to weigh in is to point us to a study we haven't cited (check the evidence table above first), or to flag a problem with one we have. Every submission is reviewed; if it holds up, the grade updates and shows in Science Changes Its Mind.
Opens a short form. You'll sign in with Google so submissions are tied to a real account — we don't display your identity, and we only accept a link we can verify (PubMed, DOI, ClinicalTrials.gov).
Educational only, not medical advice. Grades and scores reflect published evidence weighted by study design and quality; see the methodology.